Recruiting
Phase 3

Ustekinumab

Sponsor:

Janssen Research & Development, LLC

Code:

NCT05092269

Conditions

Crohn Disease

Colitis, Ulcerative

Arthritis, Psoriatic

Eligibility Criteria

Sex: All

Age: 2 - 17

Healthy Volunteers: Not accepted

Interventions

Ustekinumab

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information